Shinobu Kawakatsu
Overview
Explore the profile of Shinobu Kawakatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayashi H, Sone T, Iokawa K, Sumigawa K, Fujita T, Kawamata H, et al.
Health Sci Rep
. 2024 Jun;
7(6):e2175.
PMID: 38895550
Background And Aims: Mild cognitive impairment (MCI) is a widespread condition in older individuals, posing significant risk of dementia. However, limited research has been conducted to explore effective interventions and...
2.
Sakamoto K, Kim K, Kobayashi R, Yokoi K, Morioka D, Kawakatsu S, et al.
Clin Park Relat Disord
. 2024 May;
10:100257.
PMID: 38778885
•A 77-year-old right-handed man experienced an infarct in the right midbrain.•Ipsilesional progressive micrographia occurred after the midbrain infarct.•Micrographia improved when the patient wrote as if practicing Japanese calligraphy.•Further studies should...
3.
Qi C, Kobayashi R, Kawakatsu S, Kametani F, Scheres S, Goedert M, et al.
Acta Neuropathol
. 2024 May;
147(1):86.
PMID: 38758288
Dominantly inherited mutation D395G in the gene encoding valosin-containing protein causes vacuolar tauopathy, a type of behavioural-variant frontotemporal dementia, with marked vacuolation and abundant filamentous tau inclusions made of all...
4.
Hashiguchi K, Kobayashi R, Morioka D, Kawakatsu S, Sakamoto K, Matsuda H, et al.
J Alzheimers Dis Rep
. 2024 May;
8(1):609-614.
PMID: 38746644
Identifying the coexistence of Lewy body (LB) pathology with Alzheimer's disease (AD) in clinical practice is important in the era of anti-amyloid-β antibody therapy. However, few studies have predicted the...
5.
Kobayashi R, Morioka D, Kawakatsu S, Sakamoto K, Suzuki A
Psychogeriatrics
. 2024 Feb;
24(3):727-728.
PMID: 38342089
No abstract available.
6.
Kobayashi R, Morioka D, Kawakatsu S, Sakamoto K, Suzuki A
Alzheimer Dis Assoc Disord
. 2024 Jan;
38(1):95-97.
PMID: 38227857
Dementia with Lewy bodies (DLB) is strongly associated with Alzheimer disease (AD)-type pathology and tends to mask the core clinical features of DLB. Therefore, there may be cases of undiagnosed...
7.
Morioka D, Kobayashi R, Kawakatsu S, Sakamoto K, Suzuki A
Psychogeriatrics
. 2024 Jan;
24(3):719-721.
PMID: 38163382
No abstract available.
8.
Shibuya Y, Kobayashi R, Numazawa T, Toyoshima T, Hayashi H, Sone T, et al.
Psychiatr Res Clin Pract
. 2023 Dec;
5(4):126-130.
PMID: 38077275
Objective: Identifying factors associated with poor outcomes in patients with delirium is important for predicting prognosis. This retrospective study developed an easy and objective cognitive function measurement scale that can...
9.
Edahiro A, Okamura T, Arai T, Ikeuchi T, Ikeda M, Utsumi K, et al.
Geriatr Gerontol Int
. 2023 Nov;
24(1):176-178.
PMID: 37990422
No abstract available.
10.
Kainuma M, Kawakatsu S, Kim J, Ouma S, Iritani O, Yamashita K, et al.
Front Pharmacol
. 2023 Jun;
14:1203349.
PMID: 37377927
Alzheimer's disease (AD), the most prevalent form of dementia, is a debilitating, progressive neurodegeneration. Amino acids play a wide variety of physiological and pathophysiological roles in the nervous system, and...